Skip to content
10-Q

Quarterly Report

vTv Therapeutics Inc. VTVT

0001641489-25-000026

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2025 · Mar 31, 2025 $31.06M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $36.75M
Stockholders Equity Q1 2025 · Mar 31, 2025 $7.92M
Stockholders Equity Q1 2025 · Dec 31, 2024 $12.2M
Current Liabilities Q1 2025 · Mar 31, 2025 $4.32M
Current Liabilities Q1 2025 · Dec 31, 2024 $5.2M
Total Liabilities Q1 2025 · Mar 31, 2025 $23.13M
Total Liabilities Q1 2025 · Dec 31, 2024 $23.97M
Current Assets Q1 2025 · Mar 31, 2025 $31.92M
Current Assets Q1 2025 · Dec 31, 2024 $38.11M
Total Assets Q1 2025 · Mar 31, 2025 $32.03M
Total Assets Q1 2025 · Dec 31, 2024 $38.27M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$7.34M
Sga Expense Q1 2025 · Mar 31, 2024 $3.98M
Rd Expense Q1 2025 · Mar 31, 2024 $2.65M
Net Income Q1 2025 · Mar 31, 2024 −$4.87M
Operating Income Q1 2025 · Mar 31, 2024 −$5.63M
Revenue Q1 2025 · Mar 31, 2024 $1M